Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 1;75(9):2702-2704.
doi: 10.1093/jac/dkaa195.

Lopinavir pharmacokinetics in COVID-19 patients

Matthieu Gregoire  1   2 , Paul Le Turnier  3 , Benjamin J Gaborit  3 , Gwenaelle Veyrac  4 , Raphaël Lecomte  3 , David Boutoille  3 , Emmanuel Canet  5 , Berthe-Marie Imbert  6 , Ronan Bellouard  1 , François Raffi  3
Affiliations

Lopinavir pharmacokinetics in COVID-19 patients

Matthieu Gregoire et al. J Antimicrob Chemother. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Lopinavir concentrations in SARS-CoV-2-infected patients after ritonavir-boosted lopinavir 400/100 mg once or twice daily. Total (black) and unbound (grey) concentrations are represented by medians, IQRs and ranges at peak (4 ± 1 h after intake) or trough (q12h: at least 10 h after intake; and q24h: at least 18 h after intake).
See this image and copyright information in PMC

References

    1. Choy K-T, Yin-Lam Wong A. et al. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res 2020; 178: 104786. - PMC - PubMed
    1. Illamola SM, Labat L, Benaboud S. et al. Determination of total and unbound concentrations of lopinavir in plasma using liquid chromatography–tandem mass spectrometry and ultrafiltration methods. J Chromatogr B 2014; 965: 216–23. - PubMed
    1. Boffito M, Back DJ, Hoggard PG. et al. Intra-individual variability in lopinavir plasma trough concentrations supports therapeutic drug monitoring. AIDS 2003; 17: 1107–8. - PubMed
    1. Morgan ET. Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics. Clin Pharmacol Ther 2009; 85: 434–8. - PMC - PubMed
    1. Ofotokun I, Lennox JL, Eaton ME. et al. Immune activation mediated change in alpha-1-acid glycoprotein: impact on total and free lopinavir plasma exposure. J Clin Pharmacol 2011; 51: 1539–48. - PMC - PubMed

MeSH terms